NASDAQ:BCPC - Balchem Stock Price, Forecast & News

Balchem trades on the NASDAQ under the ticker symbol "BCPC."

Balchem announced an annual dividend on Wednesday, December 12th. Stockholders of record on Wednesday, December 26th will be given a dividend of $0.47 per share on Friday, January 18th. This represents a dividend yield of 0.59%. The ex-dividend date of this dividend is Monday, December 24th. This is an increase from Balchem's previous annual dividend of $0.42. View Balchem's Dividend History.

Balchem Co. (NASDAQ:BCPC) issued its quarterly earnings results on Tuesday, November, 5th. The basic materials company reported $0.81 EPS for the quarter, topping analysts' consensus estimates of $0.74 by $0.07. The basic materials company had revenue of $158.60 million for the quarter, compared to analyst estimates of $166.42 million. Balchem had a return on equity of 14.01% and a net margin of 12.43%. The business's revenue was up 2.3% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.73 earnings per share. View Balchem's Earnings History.

Balchem is scheduled to release their next quarterly earnings announcement on Thursday, February 27th 2020. View Earnings Estimates for Balchem.

3 Wall Street analysts have issued 1-year target prices for Balchem's shares. Their forecasts range from $100.00 to $110.00. On average, they expect Balchem's stock price to reach $105.00 in the next twelve months. This suggests a possible upside of 4.0% from the stock's current price. View Analyst Price Targets for Balchem.

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Balchem in the last year. There are currently 2 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Balchem.

Media coverage about BCPC stock has trended somewhat negative recently, according to InfoTrie. The research firm identifies negative and positive press coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. Balchem earned a coverage optimism score of -1.7 on InfoTrie's scale. They also gave news headlines about the basic materials company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the company's share price in the next several days. View News Stories for Balchem.

Balchem saw a increase in short interest during the month of October. As of October 15th, there was short interest totalling 739,100 shares, an increase of 5.5% from the September 15th total of 700,800 shares. Based on an average daily trading volume, of 111,400 shares, the short-interest ratio is currently 6.6 days. Approximately 2.3% of the shares of the stock are sold short. View Balchem's Current Options Chain.

Some companies that are related to Balchem include Ecolab (ECL), Sherwin-Williams (SHW), International Flavors & Fragrances (IFF), Celanese (CE), RPM International (RPM), Albemarle (ALB), NewMarket (NEU), Ashland Global (ASH), W. R. Grace & Co (GRA), Sensient Technologies (SXT), Quaker Chemical (KWR), HB Fuller (FUL), Innospec (IOSP), PolyOne (POL) and Stepan (SCL).

Based on aggregate information from My MarketBeat watchlists, some companies that other Balchem investors own include Opko Health (OPK), CVS Health (CVS), Glacier Bancorp (GBCI), Starbucks (SBUX), Innovative Industrial Properties (IIPR), Texas Pacific Land Trust (TPL), Analog Devices (ADI), NVIDIA (NVDA), Tractor Supply (TSCO) and AvalonBay Communities (AVB).

Balchem's stock is owned by a variety of of institutional and retail investors. Top institutional investors include State Street Corp (2.94%), Conestoga Capital Advisors LLC (2.53%), GW&K Investment Management LLC (1.21%), Stephens Investment Management Group LLC (1.15%), Tributary Capital Management LLC (0.67%) and Capital Investment Services of America Inc. (0.40%). Company insiders that own Balchem stock include Daniel E Knutson, David F Ludwig and Scott C Mason. View Institutional Ownership Trends for Balchem.

BCPC stock was sold by a variety of institutional investors in the last quarter, including Millennium Management LLC, Stephens Investment Management Group LLC, Tributary Capital Management LLC, Scout Investments Inc., Barclays PLC, Squarepoint Ops LLC, Conestoga Capital Advisors LLC and Bath Savings Trust Co. View Insider Buying and Selling for Balchem.

BCPC stock was purchased by a variety of institutional investors in the last quarter, including GW&K Investment Management LLC, State of Alaska Department of Revenue, California Public Employees Retirement System, First Trust Advisors LP, Comerica Bank, Capital Investment Services of America Inc., Rhumbline Advisers and SG Americas Securities LLC. Company insiders that have bought Balchem stock in the last two years include Daniel E Knutson and Scott C Mason. View Insider Buying and Selling for Balchem.

Shares of BCPC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of BCPC stock can currently be purchased for approximately $100.95.

Balchem has a market capitalization of $3.25 billion and generates $643.68 million in revenue each year. The basic materials company earns $78.57 million in net income (profit) each year or $3.01 on an earnings per share basis. Balchem employs 1,135 workers across the globe.View Additional Information About Balchem.

The official website for Balchem is http://www.balchem.com/.

Balchem's mailing address is 52 Sunrise Park Road, NEW HAMPTON NY, 10958. The basic materials company can be reached via phone at 845-326-5600 or via email at [email protected]